Comment 266 |
Progress in gene therapy — are hospital pharmacies the next barrier? 266
By Julie Simpson, MRPharmS
Hospital Pharmacist 2006;13:266
Full Text PDF (50K)
|
| Top |
News 269-271 |
News summary 269-271
Hospital Pharmacist 2006;13:269-271
Headlines PDF (530K)
-Medicines management reflects
trusts' strengths and weaknesses
-Consultation on NHS pension changes under way for staff in England
and Wales
-Medical research compromised by new laws and budgets, doctors warn
-UK hospitals are poorly prepared for a major incident
-Independent prescribers could qualify by the end of the year
-MPs briefed on hospital pharmacy
|
| Top |
Special feature: Acromegaly 273-288 |
Life-long learning
— clinical manifestations and diagnosis 273-278
Acromegaly is a clinical condition caused by the hypersecretion of growth hormone, usually as a result of a benign tumour in the pituitary gland. The first part of this special feature describes the clinical features and diagnosis of the condition
Hospital Pharmacist 2006;13:273-278
Summary PDF (1
MB)
— treatment options and management 281-288
Acromegaly is usually treated by surgery to remove
the pituitary adenoma, but adjunctive treatment with drugs and radiotherapy is
also necessary. This article describes the treatment options and the importance
of long-term monitoring
Hospital Pharmacist 2006;13:281-288
Summary PDF (240K)
|
| Top |
Careers 289-290 |
Careers
A career as … a supplementary prescriber 289-290
By Anthony Young, MSc, MRPharmS, Helen Pickles, MSc, MRPharmS, Kathleen Boyle,
MRPharmS, Mark Thomas, MRPharmS, Nicola Rudall, MSc, MRPharmS, Neil Gammack,
MSc, MRPharmS, David Sproates, MRPharmS and June Beeby, MRPharmS
Eight pharmacists are currently registered as supplementary
prescribers at Gateshead Health NHS Foundation Trust. This article describes
their roles, in order to provide an insight into the opportunities presented
by this way of working
Hospital Pharmacist 2006;13:289-290
Full Text PDF (170K)
|
| Top |
Articles 291-294 |
Assessing junior doctors — how pharmacists can be prepared 291-294
By Barry Jubraj, MSc, MRPharmS, MCPP
Following changes to the training of junior doctors,
hospital pharmacists may now be asked to play a formal role in their assessment.
This article describes the tool that pharmacists will use to do this, and how
one pharmacy department is taking steps to prepare pharmacists for this role
Hospital Pharmacist 2006;13:291-294
Summary PDF (240K)
|
| Top |
Papers 295-298 |
Shelf-life prediction of intravenous busulfan by isothermal calorimetry 295-298
By Simon Gaisford, PhD, MRSC, Michael O’Neill, PhD, Lucy Thompson,
BSc, MRPharmS,
and Kai-Loke Chan, BPharm, PGDip, MRPharmS
OBJECTIVE To use isothermal calorimetry to measure
the degradation of reconstituted busulfan at a number of elevated temperatures
and to use these data to determine whether the shelf-life of the product could
safely be increased from its current period of 15h
Hospital Pharmacist 2006;13:295-298
Abstract PDF (220K)
|
| Top |
Focus on technicians 299-300 |
Focus on technicians
Developing a database to manage use of unlicensed medicines 299-300
By Paul Townsend
When an unlicensed medicine is prescribed, various
administrative requirements need to be met before the drug can be dispensed.
To manage these, a database has been developed at Birmingham Children’s
Hospital, which is described in this article
Hospital Pharmacist 2006;13:299-300
Full
Text PDF (290K)
|
| Top |
Life-long learning 301-302 |
Life-long learning
QUESTIONS: Acromegaly 301-302
Hospital Pharmacist 2006;13:301-302
PDF (110K)
ANSWERS: Venous thromboembolism 302
Hospital Pharmacist 2006;13:302
Full Text
|
| Top |